Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Leslie, Spangler"'
Autor:
Leslie Spangler, Carrie M. Nielson, M. Alan Brookhart, Rohini K. Hernandez, Robert Kees Stad, Tzu‐Chieh Lin
Publikováno v:
JBMR Plus, Vol 7, Iss 10, Pp n/a-n/a (2023)
Abstract Osteoporosis and cardiovascular disease are common in older adults. Treatment of osteoporosis reduces the burden of debilitating fractures; however, it is important to understand the benefit versus risk of treatment. This study evaluates the
Externí odkaz:
https://doaj.org/article/129cec94551548f8a9a3a4343cd3a9c5
Autor:
Min Kim, Tzu‐Chieh Lin, Tarun Arora, Hong Zhao, Akhila Balasubramanian, Robert Kees Stad, James O'Kelly, Leslie Spangler, Brian D. Bradbury, Jeffrey R. Curtis
Publikováno v:
Journal of Bone and Mineral Research.
Publikováno v:
Clinical Epidemiology
Lauren AS Stevens,1 Leslie Spangler,2 Laura Yochum,1 Yan Ding,1 Florence T Wang1 1Optum Epidemiology, Optum, Boston, MA, USA; 2Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, USACorrespondence: Florence T WangOptum Epidemiology, Op
Autor:
Vera Ehrenstein, Diane Reams, M. Alan Brookhart, Leah J. McGrath, Henrik Toft Sørensen, Leslie Spangler, Sara N. Levintow, Jeffrey R. Curtis, Bradley Saul, Brian D. Bradbury
Publikováno v:
McGrath, L J, Spangler, L, Curtis, J R, Ehrenstein, V, Sørensen, H T, Saul, B, Levintow, S N, Reams, D, Bradbury, B D & Brookhart, M A 2020, ' Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States ', Pharmacoepidemiology and Drug Safety, vol. 29, no. 8, pp. 854-863 . https://doi.org/10.1002/pds.5037
Purpose: In contrast to randomized clinical trials, comparative safety and effectiveness assessments of osteoporosis medications in clinical practice may be subject to confounding by indication. We used negative control outcomes to detect residual co
Autor:
Leslie Spangler, Cathy W. Critchlow, Mazhar Iqbal, A. Taylor, J. Bayly, Andrew Roddam, Samara Ferguson, Maurille Feudjo Tepie
Publikováno v:
Journal of Evaluation in Clinical Practice. 22:31-39
Rationale, aims and objectives Clinical trial data suggest that patients who have received bisphosphonates continue to benefit from them after discontinuation. However, data from real-world clinical practice are inconclusive. We assessed the impact o
Autor:
Jessica Baker, Leslie Spangler, Risa Kagan, Andrea Singer, Christopher E. Colby, Karissa Johnston, Irene Agodoa, A. Exuzides, Cynthia D. O'Malley
Publikováno v:
Mayo Clinic Proceedings. 90:53-62
Objectives: To provide a national estimate of the incidence of hospitalizations due to osteoporotic fractures (OFs) in women; compare this with the incidence of myocardial infarction (MI), stroke, and breast cancer; and assess temporal trends in the
Autor:
George Ioannidis, Akhila Balasubramanian, Robert Bensen, Celia J. F. Lin, Rod Rodjanapiches, William G. Bensen, Arthur N. Lau, Matthew Wong-Pack, Jonathan D. Adachi, Nicola Pannacciulli, Patrick Roy-Gayos, Sally W. Wade, Leslie Spangler
Publikováno v:
The Journal of rheumatology. 45(2)
Objective.Previous studies combining biologic disease-modifying antirheumatic drugs (bDMARD) to treat rheumatoid arthritis (RA) have shown an increased risk of infection. However, the risk of infection with concurrent use of denosumab, a biologic age
Autor:
Rongling Li, Suzette J. Bielinski, Melissa A. Basford, Katherine M. Newton, Leslie Spangler, Christopher G. Chute, Luke V. Rasmussen, Iftikhar J. Kullo, Joshua C. Denny, Richard L. Berg, Peggy L. Peissig, Vidhu Choudhary, Jennifer A. Pacheco, Abel N. Kho
Publikováno v:
Journal of the American Medical Informatics Association. 20:e147-e154
Background Genetic studies require precise phenotype definitions, but electronic medical record (EMR) phenotype data are recorded inconsistently and in a variety of formats. Objective To present lessons learned about validation of EMR-based phenotype
Autor:
Leslie Spangler, Onchee Yu, Thy P. Do, Denise M. Boudreau, Delia Scholes, Cathy W. Critchlow, Monica Fujii, Susan M. Ott
Publikováno v:
Bone. 52:596-601
Objective To evaluate the accuracy of using ICD-9 codes to identify nonunions (NU) and malunions (MU) among adults with a prior fracture code and to explore case-finding algorithms. Study design Medical chart review of potential NU ( N = 300) and MU
Autor:
Leslie Spangler, Andrea Z. LaCroix, Nancy Gell, Laura Ichikawa, Rebecca A. Hubbard, Delia Scholes, Belinda H. Operskalski, Susan M. Ott
Publikováno v:
Menopause (New York, N.Y.), vol 23, iss 2
Scholes, Delia; LaCroix, Andrea Z; Hubbard, Rebecca A; Ichikawa, Laura E; Spangler, Leslie; Operskalski, Belinda H; et al.(2016). Oral contraceptive use and fracture risk around the menopausal transition. Menopause, 23(2), 166-174. doi: 10.1097/gme.0000000000000595. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/62d1293x
Scholes, Delia; LaCroix, Andrea Z; Hubbard, Rebecca A; Ichikawa, Laura E; Spangler, Leslie; Operskalski, Belinda H; et al.(2016). Oral contraceptive use and fracture risk around the menopausal transition. Menopause, 23(2), 166-174. doi: 10.1097/gme.0000000000000595. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/62d1293x
ObjectiveThe effect of oral contraceptive (OC) use on risk of fracture remains unclear, and use during later reproductive life may be increasing. To determine the association between OC use during later reproductive life and risk of fracture across t